Arena Pharmaceuticals Inc
ARNA
ARNA was delisted on the 10th of March, 2022.
134 hedge funds and large institutions have $629M invested in Arena Pharmaceuticals Inc in 2013 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 43 increasing their positions, 47 reducing their positions, and 28 closing their positions.
10% more capital invested
Capital invested by funds: $571M → $629M (+$57.6M)
9% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 47
4% less funds holding
Funds holding: 140 → 134 (-6)
21% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 28
44% less call options, than puts
Call options by funds: $34.3M | Put options by funds: $61.2M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$13.4M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$13.3M |
| 3 |
SC
Samlyn Capital
New York
|
+$7.25M |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$4.64M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.38M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$26.4M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$14.9M |
| 3 |
Morgan Stanley
New York
|
-$3.94M |
| 4 |
State Street
Boston,
Massachusetts
|
-$3.83M |
| 5 |
CA
Commerzbank Aktiengesellschaft
Frankfurt,
Germany
|
-$3.15M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BJ
151
BlackRock Japan
Tokyo,
Japan
| – | -$97K | -1,844 | Closed |
|
|
CHAM
152
Clear Harbor Asset Management
Stamford,
Connecticut
| – | -$79K | -1,500 | Closed |
|
|
PAM
153
Premier Asset Management
Chicago,
Illinois
| – | -$63K | -1,200 | Closed |
|
|
GHA
154
GW Henssler & Associates
Kennesaw,
Georgia
| – | -$56K | -1,056 | Closed |
|
|
GPA
155
GSB Podium Advisors
New York
| – | -$55K | -1,050 | Closed |
|
|
MWR
156
McAdams Wright Ragen
Seattle,
Washington
| – | -$53K | -1,000 | Closed |
|
|
FQ
157
First Quadrant
Glendale,
California
| – | -$48K | -920 | Closed |
|
|
FNYS
158
First New York Securities
New York
| – | -$26K | -500 | Closed |
|
|
PAS
159
Partnervest Advisory Services
Santa Barbara,
California
| – | -$21K | -400 | Closed |
|
|
WA
160
WealthTrust-Arizona
Scottsdale,
Arizona
| – | -$6.27K | -120 | -99% |
|
161
Dimensional Fund Advisors
Austin,
Texas
| – | -$2K | -40 | Closed |
|
ARNA Hedge Fund Activity: Q4 2013 in Review
134 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q4 2013, worth a combined $629M — up 10% from $571M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of ARNA and 22 opened new positions — a net loss of 6 holders — while 47 trimmed existing stakes and 43 added.
The largest buyer was Susquehanna International Group, adding an estimated $13.4M. The largest seller was Capital World Investors, exiting entirely with an estimated $26.4M sold.
- 134 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q4 2013, down from 140 in Q3 2013.
- Funds reported $629M of Arena Pharmaceuticals Inc stock for Q4 2013, up 10% quarter-over-quarter.
- 22 funds opened new Arena Pharmaceuticals Inc positions in Q4 2013 and 28 closed out, a net change of -6 holders.
- The largest Arena Pharmaceuticals Inc buyer in Q4 2013 was Susquehanna International Group, an estimated $13.4M added.
- The largest Arena Pharmaceuticals Inc seller in Q4 2013 was Capital World Investors, an estimated $26.4M sold.
Based on aggregated 13F filings for Q4 2013.